公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | Develop companion radiopharmaceutical YKL40 antibodies as potential theranostic agents for epithelial ovarian cancer | Chang, Ming-Cheng; Chiang, Ping-Fang; Kuo, Yu-Jen; Peng, Cheng-Liang; I-CHUN CHEN ; Huang, Chia-Yen; CHI-AN CHEN ; YING-CHENG CHIANG | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 1 | 1 | |
2019 | Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model | TZU-PIN LU ; KUAN-TING KUO ; Chen, Ching-Hsuan; Chang, Ming-Cheng; Lin, Hsiu-Ping; Hu, Yu-Hao; YING-CHENG CHIANG ; WEN-FANG CHENG ; CHI-AN CHEN | Cancers | 17 | 14 | |
2023 | Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome | PO-HAN LIN ; YU-WEN TIEN ; WEN-FANG CHENG ; YING-CHENG CHIANG ; Wu, Chien-Huei; Yang, Karen; CHIUN-SHENG HUANG | Journal of Gynecologic Oncology | 0 | | |
2021 | A DNA Damage Response Gene Panel for Different Histologic Types of Epithelial Ovarian Carcinomas and Their Outcomes | YING-CHENG CHIANG ; PO-HAN LIN ; TZU-PIN LU ; KUAN-TING KUO ; YI-JOU TAI ; HENG-CHENG HSU ; CHIA-YING WU ; Lee, Chia-Yi; Shen, Hung; CHI-AN CHEN ; WEN-FANG CHENG | Biomedicines | 3 | 3 | |
2013 | Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients | YING-CHENG CHIANG ; Chang M.-C.; Chen P.-J.; Wu M.-M.; CHANG-YAO HSIEH ; WEN-FANG CHENG ; CHI-AN CHEN | Endocrine-Related Cancer | 19 | 19 | |
2015 | Establishment of a New Ovarian Cancer Cell Line CA5171 | YING-CHENG CHIANG ; WEN-FANG CHENG ; Chang M.-C.; TZU-PIN LU ; KUAN-TING KUO ; Lin H.-P.; CHANG-YAO HSIEH ; CHI-AN CHEN | Reproductive Sciences | 5 | 6 | |
2021 | Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors | Shen, Hung; HENG-CHENG HSU ; YI-JOU TAI ; KUAN-TING KUO ; CHIA-YING WU ; YEN-LING LAI ; YING-CHENG CHIANG ; YU-LI CHEN ; WEN-FANG CHENG | Frontiers in oncology | 5 | 5 | |
2018 | Factors predicting parametrial invasion in patients with early-stage cervical carcinomas | HENG-CHENG HSU ; YI-JOU TAI ; YU-LI CHEN ; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | PLoS ONE | 14 | 14 | |
2015 | Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas | CHI-AN CHEN ; YING-CHENG CHIANG ; Chang M.-C.; Hu Y.-H.; You S.-L.; Cheng Y.-Y.K.; Chou C.-Y.; WEN-FANG CHENG | American Journal of Translational Research | 8 | | |
2016 | Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup | JEN-CHIEH LEE ; TZU-PIN LU ; Changou C.A.; Liang C.-W.; Huang H.-N.; Lauria A.; Huang H.-Y.; Lin C.-Y.; YING-CHENG CHIANG ; Davidson B.; Lin M.-C.; KUAN-TING KUO | Modern Pathology | 23 | 21 | |
2009 | High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma | WEN-FANG CHENG ; Huang C.-Y.; Chang M.-C.; Hu Y.-H.; YING-CHENG CHIANG ; YU-LI CHEN ; CHANG-YAO HSIEH ; CHI-AN CHEN | British Journal of Cancer | 117 | 112 | |
2013 | High-risk human papillomavirus, other than type 16/18, in predominantly older Taiwanese women with high-grade cervical preinvasive lesions | YING-CHENG CHIANG ; WEN-FANG CHENG ; YU-LI CHEN ; Chang M.-C.; CHANG-YAO HSIEH ; Lin M.-C.; CHI-AN CHEN | Taiwanese Journal of Obstetrics and Gynecology | 9 | 9 | |
2021 | Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction | YING-CHENG CHIANG ; PO-HAN LIN ; WEN-FANG CHENG | Frontiers in Oncology | 14 | 13 | |
2021 | Hyaluronan-Loaded Liposomal Dexamethasone-Diclofenac Nanoparticles for Local Osteoarthritis Treatment | Chang, Ming-Cheng; Chiang, Ping-Fang; Kuo, Yu-Jen; Peng, Cheng-Liang; Chen, Kuan-Yin; YING-CHENG CHIANG | International journal of molecular sciences | 29 | 22 | |
2019 | Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes | Sun N.-Y.; U-LI CHEN ; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; YI-JOU TAI ; CHI-AN CHEN ; WEI-ZEN SUN ; CHUNG-LIANG CHIEN ; WEN-FANG CHENG | Cancer Letters | 12 | 13 | |
2018 | Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation | YU-LI CHEN ; Chang M.-C.; YING-CHENG CHIANG ; Lin H.-W.; Sun N.-Y.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Cancer Letters | 31 | 29 | |
2019 | Impact of adjuvant modalities on survival in patients with advanced stage endometrial carcinoma: A retrospective analysis from a tertiary medical center | YI-JOU TAI ; HENG-CHENG HSU ; YING-CHENG CHIANG ; YU-LI CHEN ; CHI-AN CHEN ; WEN-FANG CHENG | International Journal of Environmental Research and Public Health | 9 | 8 | |
2014 | Impact of management on the prognosis of pure uterine papillary serous cancer - A Taiwanese Gynecologic Oncology Group (TGOG) study | Huang C.-Y.; Tang Y.-H.; YING-CHENG CHIANG ; Wang K.-L.; Fu H.-C.; Ke Y.-M.; Lau H.-Y.; Hsu K.-F.; Wu C.-H.; WEN-FANG CHENG | Gynecologic Oncology | 29 | 26 | |
2011 | Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinoma | YU-LI CHEN ; Ho C.-M.; CHI-AN CHEN ; YING-CHENG CHIANG ; Huang C.-Y.; CHANG-YAO HSIEH ; WEN-FANG CHENG | International Journal of Gynecology and Obstetrics | 6 | 6 | |
2021 | Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population-based analysis | YEN-LING LAI ; CHUN-JU CHIANG ; YU-LI CHEN ; You, San-Lin; Chen, Yun-Yuan; YING-CHENG CHIANG ; YI-JOU TAI ; HENG-CHENG HSU ; CHI-AN CHEN ; WEN-FANG CHENG | Cancer medicine | 3 | 3 | |